61
Participants
Start Date
April 19, 2022
Primary Completion Date
January 7, 2026
Study Completion Date
December 31, 2026
Durvalumab
Fixed dose of 1500 mg via IV infusion upon enrollment visit and every 4 weeks thereafter.
Research Site, Taipei
Research Site, Taoyuan District
Research Site, Taichung
Research Site, Tainan City
Research Site, Budapest
Research Site, Quezon City
Research Site, Sofia
Research Site, Sofia
Research Site, Melbourne
Research Site, Box Hill
Research Site, Charleroi
Research Site, Székesfehérvár
Research Site, Győr
Research Site, Bangkok
Research Site, Marseille
Research Site, Athens
Research Site, Santiago de Compostela
Research Site, Bursa
Research Site, Girona
Research Site, Milan
Research Site, Milan
Research Site, Aguascalientes
Research Site, Vinnytsia
Research Site, Dijon
Research Site, Besançon
Research Site, Oldenburg
Research Site, Madrid
Research Site, Brest
Research Site, Marbella
Research Site, Toulouse
Research Site, Bordeaux
Research Site, Gütersloh
Research Site, Montpellier
Research Site, Istanbul
Research Site, Rennes
Research Site, Izmir
Research Site, Padua
Research Site, Tours
Research Site, Memphis
Research Site, Modena
Research Site, Saint-Herblain
Research Site, Valencia
Research Site, Meldola
Research Site, Münster
Research Site, Dnipro
Research Site, Busan
Research Site, Chiang Mai
Research Site, Arezzo
Research Site, Pisa
Research Site, Chernivtsi
Research Site, Gwangju
Research Site, Strasbourg
Research Site, Lyon
Research Site, Ho Chi Minh City
Research Site, Bari
Research Site, Ivano-Frankivsk
Research Site, Rouen
Research Site, Denver
Research Site, Kyiv
Research Site, Uzhhorod
Research Site, Hat Yai
Research Site, Newport Beach
Research Site, Kuching
Research Site, Villejuif
Research Site, Catania
Research Site, Mérida
Research Site, Hanoi
Research Site, Beijing
Research Site, Beijing
Research Site, Moscow
Research Site, Shenyang
Research Site, Moscow
Research Site, Singapore
Research Site, Singapore
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Shanghai
Research Site, Shanghai
Research Site, Nanjing
Research Site, Hangzhou
Research Site, Hangzhou
Research Site, Hangzhou
Research Site, Wenzhou
Research Site, Xiamen
Research Site, Changsha
Research Site, Chennai
Research Site, Nizhny Novgorod
Research Site, Novosibirsk
Research Site, Omsk
Research Site, Hồ Chí Minh
Research Site, Xi'an
Research Site, Suceava
Research Site, Rosario
Research Site, Barretos
Research Site, São José do Rio Preto
Research Site, Kingston
Research Site, Newmarket
Research Site, Toronto
Research Site, Olomouc
Research Site, Roma
Research Site, Roma
Research Site, Bunkyō City
Research Site, Fukuoka
Research Site, Kanazawa
Research Site, Kōtoku
Research Site, Nagoya
Research Site, Okayama
Research Site, Saga
Research Site, Sunto-gun
Research Site, Mexico City
Research Site, Bialystok
Research Site, Bydgoszcz
Research Site, Elblag
Research Site, Lodz
Research Site, Lodz
Research Site, Olsztyn
Research Site, Szczecin
Research Site, Warsaw
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Barcelona
Research Site, Barcelona
Research Site, Lausanne
Research Site, Taichung
Research Site, Ankara
Research Site, Ankara
Research Site, Ankara
Research Site, London
Research Site, Sheffield
Lead Sponsor
AstraZeneca
INDUSTRY